Synthesis, Biological Investigation, and Structural Revision of Sielboldianin A.
Renate KristianslundMarius AursnesJørn E TungenCarl H GörbitzTrond Vidar HansenPublished in: Journal of natural products (2018)
The two ar-bisabol sesquiterpenoids (+)-sielboldianin A (1) and (+)-sielboldianin B (2) were isolated from the stem bark of the plant Fraxinus sielboldiana and belong to a medicinally interesting class of natural products used in traditional Chinese medicine. Herein the total synthesis of the proposed structure of (+)-sielboldianin A (1) is reported using an organocatalyzed enantioselective bromolactonization protocol. X-ray analysis of a key intermediate together with specific rotation values and NOESY data of the synthesized product enabled the revision of the absolute configuration of the natural product (+)-sielboldianin A to (7 R,10 R). Studies on the antioxidant effects using two cell-based assays were conducted. These studies revealed that the enantiomer of 1 exhibited antioxidant effects with IC50 values of 18 ± 3 μM in a cellular lipid peroxidation antioxidant activity assay. Moreover, (-)-1 showed strong protective effects against reactive oxygen species in a cell-based antioxidant activity assay (IC50 = 31 ± 5 μM). In addition, the two ar-sesquiterpenoids (-)-boivinianin B and (-)-gossoronol showed no effect in either assay. No cytotoxic activity in the K562 cancer cell line was observed for the three sesquiterpenoids tested (IC50 > 50 μM).
Keyphrases
- high throughput
- single cell
- total knee arthroplasty
- reactive oxygen species
- cell therapy
- oxidative stress
- randomized controlled trial
- total hip arthroplasty
- high resolution
- case control
- papillary thyroid
- electronic health record
- computed tomography
- big data
- squamous cell carcinoma
- machine learning
- mass spectrometry
- young adults
- artificial intelligence
- deep learning
- cell wall
- contrast enhanced